PremiumCompany AnnouncementsClarity Pharmaceuticals Advances SECuRE Trial with Enhanced Prostate Cancer Treatment Clarity Pharmaceuticals Relocates Registered Office to Enhance Operations Vanguard Group Becomes Substantial Holder in Clarity Pharmaceuticals PremiumCompany AnnouncementsClarity Pharmaceuticals Secures Copper-64 Supply for Enhanced Cancer Diagnostics Clarity Pharmaceuticals Reports Key 2025 Interim Achievements Clarity Pharmaceuticals Reports Increased Loss but Stronger Asset Base PremiumCompany AnnouncementsClarity Pharmaceuticals Advances Prostate Cancer Treatment with SECuRE Trial Success Clarity Pharmaceuticals Expands Share Capital with New Issuance Clarity Pharmaceuticals Expands Market Presence with New ASX Securities Quotation